Adalimumab is a fully human monoclonal IgG1 antibody that selectively neutralizes human TNF-alpha. It is widely used in research models of rheumatoid arthritis, ankylosing spondylitis, and psoriasis, facilitating both in vitro mechanistic studies and in vivo preclinical investigations.
Concentration:
54.5 mg/mL
Molecular Weight:
145.4 kDa
Purity:
99.50% (May vary between batches)
CAS Number:
[331731-18-1]
Target:
Antibacterial,TNF
* VAT and and shipping costs not included. Errors and price changes excepted